Why Might You Not Be Eligible for a Clinical Trial
Clinical studies often seek participants with specific conditions, treatment histories and health characteristics. Learn why you may not be able to take part, even when the study concerns your condition.
What is the MHRA and why does it matter for patients?
Learn how the Medicines and Healthcare products Regulatory Agency, (MHRA) evaluates medicines, monitors safety, and oversees clinical research in the UK.
Multiple Sclerosis: What if stopping treatment could be beneficial for patients?
Discover how the TWINS study for Multiple Sclerosis, decoded by Prof. Collongues, explores treatment discontinuation to improve the quality of life and safety of stable patients.
Placebo and Nocebo Effects Explained
The placebo and nocebo effects prove that our expectations can physically change how we feel.This shows that healing is a combination of the right medicine as well as the mindset.
From Phase I to IV: Clinical Trials Explained
Before a medicine becomes available, it must pass through four phases of clinical trials. Each phase is designed to answer questions about safety, effectiveness, and proper use in patients.